Smokers Who Quit Have Metabolite Levels That Resemble Those of Nonsmokers
A new study has found that when smokers kick the habit, their metabolic profiles start to resemble those of nonsmokers’. Credit: NeydtStock/Shutterstock.com
Even after years of smoking, the body has a remarkable ability to repair itself. Now in a study appearing in ACS’ Journal of Proteome Research, scientists report that certain metabolic changes occur soon after quitting, and these changes could help explain how some ill-effects of smoking might be reversible.
Smoking kills more than 7 million people worldwide annually and is one of the most important risk factors for six of world’s eight leading causes of premature death, according to the World Health Organization. But soon after a person quits, the body begins to repair some of accumulated damage caused by smoking. In fact, according to the U.S. Centers for Disease Control and Prevention, within two to three months of quitting, lung function begins to improve and the risk of heart attack begins to diminish. A previous study published in 2013 suggested that metabolic changes that occur after smoking cessation may kick start these physiological improvements. Building on this work, Nikola Pluym and colleagues sought to hone in on what alterations smoking causes in the body’s metabolic pathways and whether any of these changes are reversible after quitting.
The researchers regularly collected blood, urine and saliva samples from male volunteers, who were trying to quit smoking, up to three months after smoking cessation. To minimize nutritional effects on metabolism, the researchers strictly controlled the volunteers’ diets during four in-patient stays. To ensure compliance, they measured levels of carbon monoxide and cotinine, a nicotine metabolite which can be detected in urine and saliva over several days after someone has smoked. In the study, the researchers analyzed the experimental samples with an untargeted metabolic fingerprinting approach. Overall, the researchers identified 52 metabolites that were significantly altered after the subjects stopped smoking, including several that showed reversible changes toward that of a nonsmoker’s metabolic profile. The team concluded that these compounds could one day be used as biomarkers for smoking-induced biological changes. Moreover, the researchers state that the published method would be also useful for evaluating the benefits, if any, for smokers when switching to new products like electronic cigarettes.
This article has been republished from materials provided by the American Chemical Society. Note: material may have been edited for length and content. For further information, please contact the cited source.
Goettel M, Niessner R, Mueller D, Scherer M, Scherer G, Pluym N. Metabolomic Fingerprinting in Various Body Fluids of a Diet-Controlled Clinical Smoking Cessation Study Using a Validated GC-TOF-MS Metabolomics Platform. J Proteome Res. 2017 Oct 6;16(10):3491-3503. doi: 10.1021/acs.jproteome.7b00128. Epub 2017 Sep 18. PubMed PMID: 28849940.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Simple Sugar Prevents Neurodegeneration in Lysosomal Storage DiseaseNews
New therapeutic approach may one day delay neurodegeneration typical of a disease called mucopolysaccharidoses IIIB (MPS IIIB)READ MORE